Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Quality Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Quality Index of 1.19x as of September 2025. Operating cash flow of CN¥670.83 Million exceeds net income of CN¥564.54 Million, indicating high earnings quality where cash backs reported profits. Explore 688578 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688578 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2021–2025)
Year-by-year earnings quality comparison for Shanghai Allist Pharmaceuticals Co. Ltd. A. For live market cap and the full company financial profile, see Shanghai Allist Pharmaceuticals Co. Ltd. (688578) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥2.32 Billion | CN¥2.18 Billion | ▼ -2.8% |
| 2024 | 1.10x | CN¥1.57 Billion | CN¥1.43 Billion | ▲ +4.6% |
| 2023 | 1.05x | CN¥674.65 Million | CN¥644.17 Million | ▲ +49.2% |
| 2022 | 0.70x | CN¥91.63 Million | CN¥130.52 Million | ▼ -56.2% |
| 2021 | 1.60x | CN¥29.29 Million | CN¥18.27 Million | — |